AstraZeneca jab: EU regulator 'firmly convinced' benefits outweigh risks

Agency says there are no indications' the vaccine causes blood clots, but the risk may be higher for some groups

• Coronavirus - latest updates
• See all our coronavirus coverage

The EU's medicines regulator has said it remains firmly convinced" the benefits of the Oxford/AstraZeneca Covid vaccine outweigh the risks, but isolated cases of blood clots are a serious concern and need serious and detailed scientific evaluation".

Emer Cooke, the head of the European Medicines Agency (EMA), said there was no indication that the shot had caused any of the incidents, but the agency was investigating them thoroughly and would report it conclusions on Thursday.